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Background
We have developed a high-throughput method to rapidly
identify the protein constructs which are well expressed
and find out which experimental factors influence their
production. From a sparse matrix designed to screen
between expression strains, culture media, lysis and puri-
fication buffers for each construct, the interactions among
variables leading to a higher yield of soluble recombinant
protein can be easily identified.
This screening is performed by a combination of small
scale fermentation in deep-well blocks, cell lysis with a 24
microtips sonicator, Ni-NTA magnetic beads purification,
and an automated gel capillary electrophoresis system,
which allows a high-throughput and quantitative analysis
of the multiple variables in one experiment.
This technique allows one to evaluate as early as possible
the expression level of the constructs, narrowing down the
number of constructs subsequently going through the
large scale fermentation and purification module.
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Table 1: 
Expression strain Culture medium Lysis and purification buffer
Condition 1 Strain 2 Medium 2 Buffer 1
Condition 2 Strain 3 Medium 1 Buffer 4
Condition 3 Strain 3 Medium 2 Buffer 2
Condition 4 Strain 1 Medium 1 Buffer 1
Condition 5 Strain 2 Medium 3 Buffer 3
Condition 6 Strain 1 Medium 3 Buffer 4
Condition 7 Strain 2 Medium 2 Buffer 4
Condition 8 Strain 1 Medium 2 Buffer 3
Condition 9 Strain 3 Medium 2 Buffer 5
Condition 10 Strain 1 Medium 1 Buffer 5
Condition 11 Strain 2 Medium 3 Buffer 5
Condition 12 Strain 3 Medium 1 Buffer 3
Condition 13 Strain 3 Medium 3 Buffer 1
Condition 14 Strain 2 Medium 1 Buffer 2
Condition 15 Strain 1 Medium 3 Buffer 2
Sparse matrix design (http://www.igs.cnrs-mrs.fr/samba/samba.html): Strain 1: BL21(DE3)/Strain 2: C43(DE3)(from OverExpress™)/Strain3: 
BL21(DE3) harboring pG-KJE8 vector from Takara Medium 1: LB/Medium 2: Auto-induction/Medium 3: Turbo broth+ Augmedium from 
AthenaES™ Buffer 1: 40 mM HEPES;150 mM NaCl;10%glycerol;pH7/Buffer 2: 40 mM HEPES;400 mM NaCl;100 mM urea;pH7/Buffer 3: PBS 
pH8/Buffer 4: 40 mM Tris;150 mM NaCl;10%glycerol;pH8.5/Buffer 5: 40 mM Tris;400 mM NaCl;100 mM urea;pH8.5Page 1 of 2
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Using a combination of robotic systems like the QIAGEN
BioRobot 3000, a microsonification device (20 kHz 24
element probe from SONICS) and an Agilent ALP5100,
we rapidly monitor in parallel and in a microtiter well for-
mat the level of expression in E. coli of the different pro-
tein constructs, in 15 different conditions (see Table 1).
We also aim at the definition at an early stage the buffer
conditions allowing protein stabilization during cell lysis
and purification (figure 1).
Quantitative analysis of a human protein purification after cell lysis and purific tion with 5 different buffers: The values wereobt ined using the ALP5100 syst mFigur  1
Quantitative analysis of a human protein purification after cell 
lysis and purification with 5 different buffers: The values were 
obtained using the ALP5100 system. The buffers 1 to 5 are 
described in the table1.
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